VOLUME
61 2000 NUMBER 9
Brainstorms
628 Paying Attention to Your Acetylcholine, Part 2: The
Function of Nicotinic Receptors.
Stephen M. Stahl
[PDF]
Original Articles
630 The Implications of Genetic Studies of Major Mood
Disorders for Clinical Practice. Anne Duffy,
Paul Grof, Carrie
Robertson, and Martin Alda
[Abstract]
[PDF]
638 A Naturalistic Comparison of Clozapine, Risperidone, and
Olanzapine in the Treatment of Bipolar Disorder. Constance
Guille, Gary S. Sachs, and S. Nassir Ghaemi
[Abstract]
[PDF]
643 A Randomized, Double-Blind, Placebo-Controlled Trial of
Moclobemide in Patients With Chronic Fatigue Syndrome. Ian B.
Hickie, Andrew J. Wilson, J. Murray Wright, Barbara K. Bennett,
Denis Wakefield, and Andrew R. Lloyd
[Abstract]
[PDF]
649 Possible Induction of Mania and Hypomania by Olanzapine or
Risperidone: A Critical Review of Reported Cases. Jean-Michel
Aubry, Andor E. Simon, and Gilles Bertschy
[Abstract]
[PDF]
656 Mirtazapine Compared With Paroxetine in Major Depression. Otto
Benkert, Armin Szegedi, and Ralf Kohnen
[Abstract]
[PDF]
664 Psychostimulant Augmentation During Treatment With
Selective Serotonin Reuptake Inhibitors in Men With Paraphilias
and Paraphilia-Related Disorders: A Case Series. Martin P.
Kafka and John Hennen
[Abstract]
[PDF]
671 Clinical and Psychopharmacologic Factors Influencing
Family Burden in Refractory Schizophrenia. Robert Rosenheck,
Joyce Cramer, George Jurgis, Deborah Perlick, Weichun Xu,
Jonathan Thomas, William Henderson, and Dennis Charney, for the
Department of Veterans Affairs Cooperative Study Group on
Clozapine in Refractory Schizophrenia
[Abstract]
[PDF]
Academic Highlights
686 Novel Antidepressant Strategies to Optimize Outcome.
[PDF]
CME Article 697
698 Psychiatric Care of Patients With Depression and Comorbid
Substance Use Disorders. Ivan D. Montoya, Dace Svikis, Steven
C. Marcus, Ana Suarez, Terri Tanielian, and Harold Alan Pincus
[Abstract]
[PDF]
Letters to the Editor
677 Association Between Premenstrual Syndrome and Depression. Claudio
N. Soares and Lee S. Cohen
[PDF]
- Reply by Catherine A. Roca, Peter J. Schmidt, and David R. Rubinow
678 Is Antipsychotic Drug-Induced Weight Gain Associated With
a Favorable Clinical Response? J. Steven Lamberti
[PDF]
- Reply by Rohan Ganguli
678 Polypharmacy of 2 Atypical Antipsychotics. Edward
Rhoads
[PDF]
- Reply by Stephen M. Stahl
680 Clarification of Anticholinergic Effects of Quetiapine. Jeffrey
M. Goldstein and Martin Brecher
[PDF]
680 Side Effect Profile of Enteric-Coated Divalproex Sodium
Versus Valproic Acid. Joseph Levine, K. N. Roy Chengappa, and
Haranath Parepally
[PDF]
681 Correction. Gelenberg AJ, McGahuey C, Laukes C, Okayli
G, Moreno F, Zentner L, and Delgado P. Mirtazapine
substitution in SSRI-induced sexual dysfunction (J Clin
Psychiatry 2000;61:356-360)
[PDF]
Book Reviews 682
Information for authors
see July 2000, pages 542-544 or our Web site at www.psychiatrist.com/author.htm